These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 34034705)
1. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. He D; Liao S; Cai L; Huang W; Xie X; You M BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705 [TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766 [TBL] [Abstract][Full Text] [Related]
4. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma. Li Z; Li F; Peng Y; Fang J; Zhou J Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856 [TBL] [Abstract][Full Text] [Related]
5. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474 [TBL] [Abstract][Full Text] [Related]
7. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients. Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131 [TBL] [Abstract][Full Text] [Related]
8. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387 [TBL] [Abstract][Full Text] [Related]
9. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
10. m Li W; Liu J; Ma Z; Zhai X; Cheng B; Zhao H Dis Markers; 2021; 2021():8859590. PubMed ID: 34234878 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas. Li J; Chen N; Gong X Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127 [TBL] [Abstract][Full Text] [Related]
12. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy. Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708 [TBL] [Abstract][Full Text] [Related]
14. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. Chen QF; Li W; Wu PH; Shen LJ; Huang ZL World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872 [TBL] [Abstract][Full Text] [Related]
15. A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma. Liu L; Chen J; Ye F; Yan Y; Wang Y; Wu J Technol Cancer Res Treat; 2024; 23():15330338241276895. PubMed ID: 39155614 [TBL] [Abstract][Full Text] [Related]
16. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
17. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
18. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma. Huang R; Chen Z; Li W; Fan C; Liu J Int J Oncol; 2020 May; 56(5):1199-1211. PubMed ID: 32319580 [TBL] [Abstract][Full Text] [Related]
19. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Yang Z; Zi Q; Xu K; Wang C; Chi Q Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence. Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]